Applies to: (examples; Faculty,Staff, Students, etc)
Faculty
Faculty
Minor edits: 6/5/2018
University of Health Sciences and Pharmacy in St. Louis (UHSP) has established this screening and targeted testing policy and protocol to help limit the spread of Tuberculosis (TB). The University conducts a screening survey of all newly hired faculty members prior to their first date of work to screen for increased TB risk and exposure, and to direct additional documentation or treatment, if necessary. Any individual identified to be at high risk for latent TB or for developing TB will be required to submit documentation of prior treatment or supply a negative TB test to UHSP and/or the clinical practice site. In the event of a positive TB test, the University will take appropriate action after consultation with the affected individual and health care professionals to protect the health and welfare of all stakeholders. This TB screening and testing policy will be administered consistent with the University's policies on equal opportunities and nondiscrimination.
Applies to newly hired or rehired faculty who work on campus. Clinical adjuncts/preceptors and residents who work off-campus will be required to follow the TB screening/testing requirements of the clinical facility. All students are covered under separate UHSP admissions and academic policies requiring proof of a negative TB test upon matriculation and prior to each academic year.
Faculty | Faculty for the purposes of this policy exclude clinical adjuncts/preceptors who do not teach on campus. Other paid faculty (full-time, part-time and adjunct) as well as contract employees paid by another institution with full-faculty privileges who will work on Ipi are included. |
University of Health Sciences and Pharmacy in St. Louis has established a policy to help limit the spread of Tuberculosis (TB). The University conducts a screening survey of all newly hired or rehired faculty members prior to their first date of work. The survey screens for increased TB risk and exposure for the purpose of determining whether additional documentation or treatment is necessary.
Faculty who respond with an affirmative answer to any of the TB Screening Questions must submit the results of a negative Tuberculosis (Tuberculin) Skin Test (TST) or Interferon Gamma Release Assay (IGRA) or medical documentation of prior treatment for latent or active TB to the Human Resources Office. Medical documentation will likely include chest x-ray and a medical report. Tuberculosis (Tuberculin) Skin Tests must have been done six months or less before beginning employment to be accepted. The faculty member is responsible for the cost of the TST and/or medical care associated with getting documentation.
Records will be maintained in the employee's OSHA/Health records file in the Human Resources Office.
Clinical pharmacy practice faculty and residents who work at off-campus facilities are exempt from the campus screening protocol but are required to supply a negative TST or IGRA or medical documentation of prior treatment for latent or active TB or other documentation to meet requirements for their clinical site. A copy of records for clinical pharmacy practice faculty and residents will be maintained by the pharmacy practice department as well as Human Resources in the OSHA/Health Records File.
The University will take appropriate steps including (without limitation) rescinding an appointment, delaying work or training, or disciplinary action up to and including discharge in order to ensure compliance with this policy.
In the event of a positive TB test, the University will review the facts and consult with the affected individual and medical providers to determine the appropriate course of action to protect the interests of all stakeholders. Due care will betaken to avoid discrimination based on stereotypes and perceived disabilities in accordance with the University's policies on equal opportunities and non-discrimination.
For covered faculty and residents:
Position/Office/Department |
Responsibility |
Human Resources |
Developing survey, issuing survey, following up to ensure compliance, records management for faculty. |
Department of Pharmacy Practice |
Maintain records of TST for practice faculty. |
Office of Post-Graduate Education |
Maintain records of TST for pharmacy residents. |
Dean of College of Pharmacy |
Work with Human Resources on clinical faculty and resident issues. |
RSMO 199.290.
Mandatory testing of health care facility workers--higher education, students and faculty, testing program required--rulemaking authority.
199.290. 1. All employees and volunteers of a health care facility shall receive a tuberculin skin test or interferon gamma release assay (IGRA) test upon employment as recommended in the most recent version of the Centersfor Disease Control and Prevention (CDC) Guidelines for Preventing Transmission of Mycobacterium Tuberculosis in Health Care Settings. If the screening test is positive, appropriate evaluation and follow-up shall be done in accordance with such CDC guidelines. This provision shall not be construed to prohibit any institution from establishing requirements for employees or volunteers that exceed those stated in the CDC guidelines.
2. All institutions of higher education in Missouri shall implement a targeted testing program on their campuses for all on-campus students and faculty upon matriculation. If an institution does not have a student health center or similar facility, such person identified by the targeted testing program to be at high riskfor latent tuberculosis infection or for developing tuberculosis disease shall be referred to a local public health agency a course of action consistent with sections 199.170 to 199.350.
RSMO 190.170(12)
The term targeted testing program as used in RSMO Section 199.290. means "program that screens all faculty and students to identify those at high riskfor latent tuberculosis infection and persons at high riskfor developing tuberculosis disease, and includes testing of identified high-risk populations to determine those that would benefit from treatment. Screening shall require the completion of a tuberculosis risk assessment questionnaire form
Name | Contact Information |
Bauer, Daniel | Daniel.Bauer@uhsp.edu or 314-446-8308 |